Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
CARPROFEN
Norbrook Laboratories Limited
QM01AE91
CARPROFEN
20 mg/tablet
Tablets
POM
Canine
Carprofen
N.S.A.I.D
Authorised
2011-03-21
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Carprieve 20 mg Flavoured Tablets for Dogs 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains: ACTIVE SUBSTANCE: Carprofen 20mg EXCIPIENTS: For the full list of excipients see section 6.1 3 PHARMACEUTICAL FORM Tablet. Light brown, round, flat, bevel edged tablet. The tablets can be divided into equal parts. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Dogs. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES For analgesia and reduction of chronic inflammation, for example in degenerative joint disease in the dog. The tablets also can be used in the management of post operative pain. 4.3 CONTRAINDICATIONS Do not exceed the stated dose. Do not use in cats. Do not use in dogs suffering from cardiac, hepatic or renal disease, where there is a possibility of gastrointestinal ulceration or bleeding, or where there is evidence of blood dyscrasia or hypersensitivity to the product. Do not use in puppies less than 4 months. Do not use in cases of hypersensitivity to active substance or to any of the excipients. Refer to section 4.7 and 4.8 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES See sections 4.3 and 4.5. HEALTH PRODUCTS REGULATORY AUTHORITY ________________________________________________________________________________________________________________________ _Date Printed 20/05/2016_ _CRN 7021311_ _page number: 1_ 4.5 SPECIAL PRECAUTIONS FOR USE i. Special precautions for use in animals: Use in aged dogs may involve additional risk. If such a use cannot be avoided, such dogs may require a reduced dosage and careful clinical management. Avoid use in any dehydrated, hypovolaemic or hypotensive dog, as there is a potential rise of increased renal toxicity. NSAIDs can cause inhibition of phagocytosis and hence i Read the complete document